PR Newswire
PORTLAND, Ore., April 22, 2026
AI-Powered Diagnostics, Telepathology Adoption, and Surging Cancer Burden Drive Accelerating Global Demand for Digital Pathology Solutions
PORTLAND, Ore., April 22, 2026 /PRNewswire/ — According to the report published by Allied Market Research, The Global Digital Pathology Market Size was estimated at USD 735.75 million in 2020 and is Anticipated to hit USD 1791.30 million by 2030, registering a CAGR of 9.3% from 2021 to 2030. Use of digital pathology in disease diagnosis, rise in the trend of digitalization in the medical sector, ease of consultation, and growth in diagnostic services in remote regions drive the growth of the global digital pathology market. On the other hand, lack of reimbursement policies and high cost of digital pathology solutions restrain the growth to some extent. However, an increase in potential of digital pathology is projected to create numerous opportunities in the industry.
https://mma.prnewswire.com/media/636519/5918347/Allied_Market_Research_Logo.jpg
Request Free Sample of the Report on Digital Pathology Market Forecast 2035 – https://www.alliedmarketresearch.com/request-sample/74
Market Size & Growth
The Digital Pathology Market size is entering into a continuous growth phase driven by fundamental factors. One seminal regulatory milestone the first FDA clearance of a whole-slide imaging (WSI) system for primary clinical diagnosis established an accessible approval pathway that has spurred widespread institutional adoption across hospitals, pharmaceutical research sites, and academic medical centers around the world.
According to this report, global Digital Pathology Market was valued at USD 735.75 million in 2020 and is projected to reach USD 1,791.30 million by 2030 at a CAGR of 9.3% from 2021 to 2030. This near doubling in market cap is driven by heavy, structural demand buoyed up by three converging trends: the spiritless unrelenting global rise of cancer incidence the WHO counted close to 20 million new cancer cases in 2022 alone the rapid integration of AI and machine learning tools into digital pathology image analysis, and a healthcare system that has permanently integrated remote diagnostics and telepathology into its operations from an emergency measure into operational standard.
Digital Pathology Market growth is non-cyclical. Irreversible megatrends chronic disease burden, aging populations, rising diagnostic volume and a well-documented global shortage of trained pathologists are driving this demand for health systems to invest in digital platforms that help enhance productivity. With digital pathology, a pathologist can process around 150 slides per day an overall efficiency gain of approximately 13% and quantifiable operational benefit that is turning institutional skepticism into dedicated capital investment.
Key Market Insights
A snapshot of key findings from Allied Market Research’s Digital Pathology Market analysis:
- In 2020, scanners segment led the global product segment market with more than two-thirds revenue share, and is anticipated to witness rapid CAGR of :9.6% throughout the forecast period.
- The Disease Diagnosis application segment was the highest revenue generating segment, contributing to more than one-third of the global market in 2020.
- In terms of regional revenue share, North America accounted for the largest market share in 2020 with nearly half of the total global Digital Pathology Market revenue driven by regulatory stability and advanced institutional adoption.
- On the other hand, Asia-Pacific is the regional market with the fastest growth rate, and it is expected to grow at a CAGR of 10.6% during the forecast period from 2021 to 2030.
- Owing to the increasing demand for new potential pipeline drugs for the treatment of life-threatening diseases, coupled with rising application of digital pathology in high-throughput screening workflows, the drug discovery application segment is expected to witness highest CAGR during the forecast period.
- Digital pathology systems can cut turnaround time by 50%, while AI-integrated platforms are yielding measurable improvements in complex oncology detection.
- Telepathology is developing as a transformative enabler of access, linking specialist pathology expertise with diagnostic settings worldwide that are underserved or located in rural areas.
Market Segmentation
The Digital Pathology Market has been segmented across Product Types, Applications and End Users with several unique commercial and clinical dynamics underlying each dimension.
From the Product Type segment, in 2020, Scanners is expected to hold the largest market share due to increase R&D activities over pharmaceutical and medical device industry with need of disease increasing demand for diagnosis and adoption of digital pathology systems. Slide scanners accompanying one another to digitize glass tissue slides into high-resolution images that can be stored, analyzed, shared and accessed remotely yield the hardware layer fundamental to every digital pathology workflow: whole-slide imaging (WSI). Software Solutions and Storage & Communication Systems are secondary segments with rapid adoption, where institutions are investing in AI-powered image analysis platforms, cloud storage infrastructure and integrated systems that can be interfaced with electronic health records (EHR) and laboratory information systems (LIS).
Market Segment by Application Teleconsultation Disease Diagnosis Drug Discovery Training & Education The largest revenue share is accounted for by the Disease Diagnosis, which reflects the principal clinical mandate(offer) of digital pathology systems. Drug Discovery is the most rapidly expanding application where pharmaceutical and biotechnology Companies harness digital platforms for quick biomarker identification, companion diagnostic development, and clinical trial tissue analysis. Rapidly growing role of teleconsultation turns it into a commonplace operational feature for remote diagnostic collaboration beyond togetherness in large multi-site hospital networks and pathology shortage mitigation programs.
Based on the End User, the market is segmented into educational institutions, clinical setting and pharma & biotech companies. The largest end-user category for revenue is clinical settings, which also includes specialist diagnostic laboratories, mainly due to the scale of demand for diagnostics and a large, institutional investment in modernising laboratory digital workflows. The fastest-growing end-user segment is in pharmaceutical and biopharmaceutical companies, as the industry continues to invest more into precision medicine and companion diagnostics. As government-funded genomics and other pathology research programs support, still academic and education institutions hold an important portion.
Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/74
Regional Insights
In 2020, the global Digital Pathology Market was led by North America as their share nearly half of total global revenue. The U.S. fosters regional leadership via pioneering FDA regulatory engagement, the largest rucksack of large footprint molecular pathology platform developers including Philips Healthcare (North American operations), Roche Diagnostics, and Indica Labs nimble NIH/private R&D funding base as well as a health care system grappling with critical pathologist shortage patatoi that renders highly efficacious digital platforms commercially undeniable. Canada adds incremental growth through leading academic-industry research partnerships at institutions in Toronto, Montreal, and Vancouver.
The regional stronghold for Europe, backed by extensive healthcare infrastructure, large government expenditure on biomedical imaging research related programs with the European Institute of Biomedical Imaging Research (EIBIR) issuing a considerable amount of funding and an established hospital network has already started benefiting from modernization in various stages of digital workflow automation. The leading national markets for European Digital Pathology Market are France (national hospital digitization initiatives), United Kingdom (NHS digital pathology programs) and Germany (strong pharmaceutical and academic demand). Italy, Spain and the Netherlands are a few other emerging secondary markets as high clinical adoption also grows.
By region, Asia-Pacific is the rapidest-growing regional marketplace and is expected to register a CAGR of 10.6% from 2021 to 2030, attributed to increasing incidence of chronic diseases and development of healthcare infrastructure in various nations around the order. China is the largest regional revenue generating country backed by national healthcare modernization investment and a hyper-accelerating pharmaceutical market. The high incidence of cancer and large aging population in Japan leads to persistent clinical demand. Within Asia-Pacific, India is growing the fastest with values increasing at their quickest rate on account of rising cancer burden, growing diagnostic infrastructure and state precision medicine campaigns. Contemporary digital pathology Hubs and Early Clinical AdoptionSouth Korea, Singapore, and Australia are iconic innovation hives for digital pathology.
And LAMEA (Latin America, Middle East & Africa), also a growing frontier, which is more particularly characterized by countries that are positioned as potential national market opportunities in the nearterm for healthcare digitization investment (Brazil, Saudi Arabia and South Africa).
𝐓𝐨𝐩 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬
- 3DHISTECH LTD
- Danaher Corporation
- Glencoe Software Inc.
- HAMAMTSU Photonics K.K
- Indica Labs Inc.
- Koninklijke Philips N.V
- Nikon Corporation
- Roche
- VisoPharma A/S
- Perkinelmer Inc.
For Purchase Related Queries/Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/74
Key Recent Industry Developments
- Leica Biosystems launched its Aperio GT 450 digital pathology scanner with DICOM-compatible files including 20x/40x magnification, Z-Stacking, Manual Scan, Extended Focus and Default Calibration features also announcing its Aperio iQC AI software to detect artifacts and optimize workflows two months ago January 2023
- February 2024: F. Hoffmann-La Roche Ltd announced a collaboration with PathAI to create AI digital pathology algorithms for Roche’s Tissue Diagnostics business with the intent of developing companion diagnostics in oncology.
- October 2023: F. Hoffmann-La Roche Ltd., Ibex Medical Analytics and Amazon Web Services will work together with their tool for enabling digital pathology and automating breast and prostate cancer diagnoses using AI-based technology.
- October 2023: Koninklijke Philips N.V. expanded its collaboration with AWS to provide secure and scalable cloud digital pathology solutions that can be seamlessly integrated into healthcare systems worldwide, helping to accelerate workflow across the continuum of care.
- In October 2022, Hamamatsu Photonics K.K., and Indica Labs partnered together to offer a streamlined holistic solution for a complete digital pathology workflow, leveraging Hamamatsu imaging hardware with the HALO image analysis platform from Indica Labs.
- January 2022: Aiforia partnered with Mayo Clinic to create a pathology research center powered by AI, which utilizes deep learning to provide quicker results and larger-scale studies in translational research.
Explore AMR’s Extensive Ongoing Coverage on Life Science Industry:
Skincare Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Medical Cannabis Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Healthcare Staffing Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
Health and Wellness Market: Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of ‘Market Research Reports’ and ‘Business Intelligence Solutions.’ AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa1209 Orange Street,Corporation Trust Center, Wilmington, New Castle,Delaware 19801 USA.Toll Free: +1-800-792-5285Int’l: +1-503-894-6022UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: [email protected]: https://www.alliedmarketresearch.com
Logo: https://mma.prnewswire.com/media/636519/5918347/Allied_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/digital-pathology-market-to-reach-usd-1-791-30-million-by-2030–growing-at-9-3-cagr-allied-market-research-302750217.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…